GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK
We assign a fundamental rating of 6 out of 10 to GENT. GENT was compared to 57 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
GENT had a positive operating cash flow in the past year.
In the past 5 years GENT reported 4 times negative net income.
In multiple years GENT reported negative operating cash flow during the last 5 years.
1.2 Ratios
GENT has a Return On Assets of 20.72%. This is amongst the best in the industry. GENT outperforms 96.49% of its industry peers.
GENT has a Return On Equity of 24.02%. This is amongst the best in the industry. GENT outperforms 91.23% of its industry peers.
GENT's Return On Invested Capital of 9.20% is fine compared to the rest of the industry. GENT outperforms 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.72% | ||
| ROE | 24.02% | ||
| ROIC | 9.2% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GENT has a Profit Margin of 30.93%. This is amongst the best in the industry. GENT outperforms 96.49% of its industry peers.
GENT has a Operating Margin of 15.72%. This is in the better half of the industry: GENT outperforms 77.19% of its industry peers.
GENT's Gross Margin of 57.48% is in line compared to the rest of the industry. GENT outperforms 57.89% of its industry peers.
In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.72% | ||
| PM (TTM) | 30.93% | ||
| GM | 57.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GENT is creating some value.
The number of shares outstanding for GENT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GENT has about the same amount of shares outstanding.
GENT has a better debt/assets ratio than last year.
2.2 Solvency
GENT has an Altman-Z score of 17.38. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
GENT has a better Altman-Z score (17.38) than 98.25% of its industry peers.
The Debt to FCF ratio of GENT is 0.56, which is an excellent value as it means it would take GENT, only 0.56 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.56, GENT belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that GENT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, GENT belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.56 | ||
| Altman-Z | 17.38 |
ROIC/WACC1.07
WACC8.59%
2.3 Liquidity
A Current Ratio of 6.08 indicates that GENT has no problem at all paying its short term obligations.
GENT has a Current ratio of 6.08. This is amongst the best in the industry. GENT outperforms 98.25% of its industry peers.
A Quick Ratio of 4.21 indicates that GENT has no problem at all paying its short term obligations.
GENT's Quick ratio of 4.21 is amongst the best of the industry. GENT outperforms 96.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.08 | ||
| Quick Ratio | 4.21 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 931.98%, which is quite impressive.
Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 11.14% in the last year.
GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.96% yearly.
EPS 1Y (TTM)931.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.46%
Revenue 1Y (TTM)11.14%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%15.58%
3.2 Future
Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 58.89% on average per year.
GENT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.72% yearly.
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.33 indicates a rather expensive valuation of GENT.
Based on the Price/Earnings ratio, GENT is valued cheaply inside the industry as 80.70% of the companies are valued more expensively.
GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 21.91, the valuation of GENT can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT is on the same level as its industry peers.
GENT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.52.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.33 | ||
| Fwd PE | 21.91 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GENT is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GENT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 113.91 | ||
| EV/EBITDA | 23.57 |
4.3 Compensation for Growth
GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GENT's earnings are expected to grow with 58.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y58.89%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.68%, GENT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.27, GENT has a dividend in line with its industry peers.
With a Dividend Yield of 0.68, GENT pays less dividend than the S&P500 average, which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.68% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y58.89%
EPS Next 3YN/A
OSL:GENT (7/17/2025, 7:00:00 PM)
57
-0.2 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap878.94M
Analysts85.71
Price Target68.34 (19.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.68% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.33 | ||
| Fwd PE | 21.91 | ||
| P/S | 5.56 | ||
| P/FCF | 113.91 | ||
| P/OCF | 50.27 | ||
| P/B | 4.32 | ||
| P/tB | 5.06 | ||
| EV/EBITDA | 23.57 |
EPS(TTM)3.11
EY5.46%
EPS(NY)2.6
Fwd EY4.56%
FCF(TTM)0.5
FCFY0.88%
OCF(TTM)1.13
OCFY1.99%
SpS10.25
BVpS13.2
TBVpS11.26
PEG (NY)0.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.72% | ||
| ROE | 24.02% | ||
| ROCE | 11.95% | ||
| ROIC | 9.2% | ||
| ROICexc | 16.06% | ||
| ROICexgc | 21.45% | ||
| OM | 15.72% | ||
| PM (TTM) | 30.93% | ||
| GM | 57.48% | ||
| FCFM | 4.88% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.56 | ||
| Debt/EBITDA | 0.13 | ||
| Cap/Depr | 108.56% | ||
| Cap/Sales | 6.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 51.66% | ||
| Profit Quality | 15.78% | ||
| Current Ratio | 6.08 | ||
| Quick Ratio | 4.21 | ||
| Altman-Z | 17.38 |
F-Score6
WACC8.59%
ROIC/WACC1.07
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)931.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.46%
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.14%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%15.58%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1545.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y139.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y399.35%
OCF growth 3YN/A
OCF growth 5YN/A